外周血白细胞端粒长度与系统性硬化症相关间质性肺病进展相关
本研究基于UCSF 213例SSc患者(其中SSc-ILD患者PBL-TL更短)的回顾性队列,采用GLMM纵向分析PBL-TL与肺功能趋势的关联,并在Stanford 61例SSc-ILD队列中验证。结果显示PBL-TL每缩短1000 bp,ILD存在风险增加(调整OR 2.1,95%CI 1.25-3.70,p=0.006),且年FEV1多下降67 mL(95%CI -104至-33 mL,p<0.001),提示端粒功能障碍可能与SSc-ILD进展相关。
要点
- SSc合并ILD患者PBL-TL较无ILD者更短(6554±671 vs 6782±698 bp,p=0.01)。
- PBL-TL每缩短1000 bp,ILD存在风险增加(调整OR 2.1,95%CI 1.25-3.70,p=0.006)。
- PBL-TL每缩短1000 bp,年FEV1多下降67 mL(95%CI -104至-33 mL,p<0.001)。
核心结论
- 端粒功能障碍可能与SSc-ILD进展相关,PBL-TL测定或可用于SSc-ILD进展风险分层。
研究设计与样本
- 回顾性观察性队列研究,使用UCSF硬皮病中心213例SSc患者前瞻性收集的数据。
- PBL-TL通过外周血DNA定量PCR测量,采用广义线性混合模型纵向分析其与肺功能趋势的关联。
- findings在Stanford大学硬皮病中心数据库61例SSc-ILD患者队列中验证。
主要发现
- UCSF队列中SSc合并ILD患者PBL-TL短于无ILD者(6554±671 bp vs 6782±698 bp,p=0.01)。
- PBL-TL缩短与ILD存在相关(每缩短1000 bp调整OR 2.1,95%CI 1.25-3.70,p=0.006)。
- SSc-ILD中缺乏SSc特异性自身抗体者PBL-TL短于血清阳性者(6237±647 bp vs 6651±653 bp,p=0.004)。
- 合并SSc-ILD队列纵向分析显示,PBL-TL每缩短1000 bp,年FEV1多下降67 mL(调整模型95%CI -104至-33 mL,p<0.001)。
临床怎么用
- 对SSc患者可考虑检测PBL-TL以辅助识别ILD进展风险较高者。
局限性
- 回顾性观察性设计,样本来自两个中心,因果关系不能确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral blood leucocyte telomere length (PBL-TL) is associated with outcomes in patients with idiopathic pulmonary fibrosis. Whether PBL-TL is associated with progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) is unknown. METHODS: A retrospective observational cohort study was performed using prospectively collected data from 213 patients with SSc followed at the University of California San Francisco (UCSF) Scleroderma Center. PBL-TL was measured by quantitative PCR of DNA isolated from peripheral blood. Associations between PBL-TL and pulmonary function test trends in patients with SSc-ILD were assessed by longitudinal analysis using Generalised Linear Mixed Models. Findings were validated in a cohort of 61 patients with SSc-ILD enrolled in the Stanford University Scleroderma Center database. RESULTS: Patients with UCSF SSc with ILD were found to have shorter PBL-TL compared with those without ILD (6554±671 base pairs (bp) vs 6782±698 bp, p=0.01). Shorter PBL-TL was associated with the presence of ILD (adjusted OR 2.1 per 1000 bp TL decrease, 95% CI [1.25 to 3.70], p=0.006). PBL-TL was shorter in patients with SSc-ILD lacking SSc-specific autoantibodies compared with seropositive subjects (6237±647 bp vs 6651±653 bp, p=0.004). Shorter PBL-TL was associated with increased risk for lung function deterioration with an average of 67 mL greater loss in per year for every 1000 bp decrease in PBL-TL in the combined SSc-ILD cohorts (longitudinal analysis, adjusted model: 95% CI -104 mL to -33 mL, p<0.001). CONCLUSIONS: These findings suggest that telomere dysfunction may be associated with SSc-ILD progression and that PBL-TL measurement may be useful for stratifying risk for SSc-ILD progression.
引用
- Liu S, Chung MP, Ley B, et al. Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis. Thorax. 2021. PMID: 34272332. doi:10.1136/thoraxjnl-2020-215918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。